Sun Pharmaceutical on Thursday said its board will consider a proposal for buyback of shares next week.
In a BSE filing, the company said, "We wish to intimate that the meeting of board of directors of the company is scheduled to be held on March 17 to consider and if deemed fit, to approve, the proposal for buyback of fully paid-up equity shares of the company, which would include maximum amount, maximum number of equity shares, mode of buy-back and other matters."